BioMed Central (BMC) is a UK-based, for-profit STM (Science, Technology and Medicine) publisher specialising in open access journal publication. BMC, and its sister companies Chemistry Central and PhysMath Central, publish over 200 scientific open access, online, peer-reviewed journals. All original research articles published by BioMed Central are made
freely and permanently accessible online immediately upon publication. BioMed Central levies an article-processing charge
to cover the cost of the publication process. Authors publishing with
BioMed Central retain the copyright to their work, licensing it under
the Creative Commons Attribution License which allows articles to be re-used and re-distributed without restriction, as long as the original work is correctly cited.
BioMed Central was founded in 2000 as part of the Current Science Group
(now Science Navigation Group, SNG), a nursery of scientific publishing
companies. SNG chairman Vitek Tracz developed the concept for the company after NIH director Harold Varmus's PubMed Central concept for open-access publishing was scaled back.
BioMed Central owns and produces in-house six flagship journals: Journal of Biology, Genome Biology, Genome Medicine, Arthritis Research and Therapy, Breast Cancer Research, and Critical Care. It also produces the BMC series of 64 journals covering the fields of biology and medicine, and including the leading titles BMC Biology and BMC Medicine.
Chemistry Central Journal and the PhysMath series of journals are also produced by the company.
No comments:
Post a Comment